RecruitMe Clinical Trial

Magnetic Resonance Spectroscopy (MRS) to assess progression of Alzheimer Disease (AD)
Magnetic Resonance Spectroscopy (MRS) to assess progression of Alzheimer Disease (AD)
Sponsor:Alzheimer's Disease Drug Discovery Foundation
Enrolling:Male and Female Patients
IRB Number:AAAK3001
Contact: Lawrence S. Honig MD: 212-305-9168 / lh456@cumc.columbia.edu
Additional Study Information:

THE PURPOSE OF THIS STUDY is to find out whether a type of brain imaging (called "Magnetic Resonance Spectroscopy Imaging" of "MRS") might be useful to help assess the presence of Alzheimer's disease (AD) and assess progression of the disease. MRS uses magnetic resonance imaging (MRI) methods to image the chemicals in the brain. You may be eligible to participate in this study as a control, or if you have mild cognitive impairment or mild Alzheimer disease.

This study is closed
Investigator
Lawrence Honig, MD, PhD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Lawrence S. Honig MD
Email: lh456@cumc.columbia.edu
Phone: 212-305-9168